IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 141 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $333,000 | -74.6% | 20,000 | -70.9% | 0.22% | -72.6% |
| Q4 2021 | $1,313,000 | -80.6% | 68,800 | -75.0% | 0.79% | -78.9% |
| Q3 2021 | $6,776,000 | +87.5% | 274,761 | +97.8% | 3.73% | +65.0% |
| Q2 2021 | $3,614,000 | -9.0% | 138,886 | +15.2% | 2.26% | +19.7% |
| Q3 2020 | $3,970,000 | -32.7% | 120,606 | -43.9% | 1.89% | -25.5% |
| Q2 2020 | $5,902,000 | -64.4% | 215,000 | -61.1% | 2.53% | -67.3% |
| Q1 2020 | $16,557,000 | +53.9% | 553,100 | +42.3% | 7.74% | +63.9% |
| Q4 2019 | $10,756,000 | +70.7% | 388,600 | +12.3% | 4.72% | +35.1% |
| Q3 2019 | $6,300,000 | -35.8% | 346,149 | -13.5% | 3.50% | -29.3% |
| Q2 2019 | $9,808,000 | +12.5% | 400,000 | -56.4% | 4.94% | +29.6% |
| Q1 2019 | $8,721,000 | -7.3% | 917,080 | -13.7% | 3.82% | -21.4% |
| Q4 2018 | $9,403,000 | +16.9% | 1,062,500 | +48.5% | 4.85% | +8.2% |
| Q3 2018 | $8,047,000 | +42.9% | 715,317 | +62.6% | 4.49% | +8.7% |
| Q2 2018 | $5,631,000 | +58.8% | 439,900 | +109.6% | 4.13% | +85.6% |
| Q1 2018 | $3,546,000 | -12.6% | 209,842 | -58.6% | 2.22% | -25.4% |
| Q4 2017 | $4,055,000 | – | 506,852 | – | 2.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |